Literature DB >> 29097123

Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Helen E Scharfman1, Andres M Kanner2, Alon Friedman3, Ingmar Blümcke4, Candice E Crocker5, Fernando Cendes6, Ramon Diaz-Arrastia7, Hans Förstl8, André A Fenton9, Anthony A Grace10, Jorge Palop11, Jason Morrison12, Astrid Nehlig13, Asuri Prasad14, Karen S Wilcox15, Nathalie Jette16, Bernd Pohlmann-Eden17.   

Abstract

There is common agreement that many disorders of the central nervous system are 'complex', that is, there are many potential factors that influence the development of the disease, underlying mechanisms, and successful treatment. Most of these disorders, unfortunately, have no cure at the present time, and therapeutic strategies often have debilitating side effects. Interestingly, some of the 'complexities' of one disorder are found in another, and the similarities are often network defects. It seems likely that more discussions of these commonalities could advance our understanding and, therefore, have clinical implications or translational impact. With this in mind, the Fourth International Halifax Epilepsy Conference and Retreat was held as described in the prior paper, and this companion paper focuses on the second half of the meeting. Leaders in various subspecialties of epilepsy research were asked to address aging and dementia or psychosis in people with epilepsy (PWE). Commonalities between autism, depression, aging and dementia, psychosis, and epilepsy were the focus of the presentations and discussion. In the last session, additional experts commented on new conceptualization of translational epilepsy research efforts. Here, the presentations are reviewed, and salient points are highlighted.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Circuit; Neurology; Neuroscience; Preclinical; Psychosis; Seizure; Systems

Mesh:

Year:  2017        PMID: 29097123      PMCID: PMC5756681          DOI: 10.1016/j.yebeh.2017.09.016

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  135 in total

Review 1.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

2.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Authors: 
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

3.  Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection.

Authors:  Jane E Libbey; Nikki J Kennett; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways.

Authors:  Mélanie Morin-Brureau; Aurore Lebrun; Marie-Claude Rousset; Laurent Fagni; Joël Bockaert; Frédéric de Bock; Mireille Lerner-Natoli
Journal:  J Neurosci       Date:  2011-07-20       Impact factor: 6.167

5.  Antiepileptic drug response in temporal lobe epilepsy: a clinical and MRI morphometry study.

Authors:  E Bilevicius; C L Yasuda; M S Silva; C A M Guerreiro; I Lopes-Cendes; F Cendes
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

Review 6.  The association between dementia and epilepsy: A systematic review and meta-analysis.

Authors:  Ann Subota; Tram Pham; Nathalie Jetté; Khara Sauro; Diane Lorenzetti; Jayna Holroyd-Leduc
Journal:  Epilepsia       Date:  2017-04-11       Impact factor: 5.864

7.  Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis.

Authors:  Luisa P Cacheaux; Sebastian Ivens; Yaron David; Alexander J Lakhter; Guy Bar-Klein; Michael Shapira; Uwe Heinemann; Alon Friedman; Daniela Kaufer
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Margarita M Behrens; Anthony A Grace
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

9.  Viral encephalitis and epilepsy.

Authors:  Usha Kant Misra; Chong Tin Tan; Jayantee Kalita
Journal:  Epilepsia       Date:  2008-08       Impact factor: 5.864

10.  Seizures following picornavirus infection.

Authors:  Jane E Libbey; Nikki J Kirkman; Matthew C P Smith; Tomoko Tanaka; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  Epilepsia       Date:  2008-03-06       Impact factor: 5.864

View more
  3 in total

1.  Neuronal Surface Antibody-Medicated Autoimmune Encephalitis (Limbic Encephalitis) in China: A Multiple-Center, Retrospective Study.

Authors:  Wei Shan; Huajun Yang; Qun Wang
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

Review 2.  Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention.

Authors:  Lívea Dornela Godoy; Tamiris Prizon; Matheus Teixeira Rossignoli; João Pereira Leite; José Luiz Liberato
Journal:  Front Integr Neurosci       Date:  2022-02-17

Review 3.  Gamma oscillations as a biomarker for major depression: an emerging topic.

Authors:  Paul J Fitzgerald; Brendon O Watson
Journal:  Transl Psychiatry       Date:  2018-09-04       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.